In this study, we performed a whole-exome analysis of 12 formalin-fixed, paraffin-embedded (FFPE) biopsies of Her2-like BC patients composed of Full Responders (FR) and Partial Responders (PR) to TRA neoadjuvant therapy. Here, ERBB2 is linked to breast cancer.